Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-8-5
pubmed:abstractText
Several gene-expression signatures predict survival in diffuse large B-cell lymphoma (DLBCL), but the lack of practical methods for genome-scale analysis has limited translation to clinical practice. We built and validated a simple model using one gene expressed by tumor cells and another expressed by host immune cells, assessing added prognostic value to the clinical International Prognostic Index (IPI). LIM domain only 2 (LMO2) was validated as an independent predictor of survival and the "germinal center B cell-like" subtype. Expression of tumor necrosis factor receptor superfamily member 9 (TNFRSF9) from the DLBCL microenvironment was the best gene in bivariate combination with LMO2. Study of TNFRSF9 tissue expression in 95 patients with DLBCL showed expression limited to infiltrating T cells. A model integrating these 2 genes was independent of "cell-of-origin" classification, "stromal signatures," IPI, and added to the predictive power of the IPI. A composite score integrating these genes with IPI performed well in 3 independent cohorts of 545 DLBCL patients, as well as in a simple assay of routine formalin-fixed specimens from a new validation cohort of 147 patients with DLBCL. We conclude that the measurement of a single gene expressed by tumor cells (LMO2) and a single gene expressed by the immune microenvironment (TNFRSF9) powerfully predicts overall survival in patients with DLBCL.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1528-0020
pubmed:author
pubmed:issnType
Electronic
pubmed:day
4
pubmed:volume
118
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1350-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21670469-Adaptor Proteins, Signal Transducing, pubmed-meshheading:21670469-Adolescent, pubmed-meshheading:21670469-Adult, pubmed-meshheading:21670469-Aged, pubmed-meshheading:21670469-Aged, 80 and over, pubmed-meshheading:21670469-Antigens, CD137, pubmed-meshheading:21670469-Child, pubmed-meshheading:21670469-Cohort Studies, pubmed-meshheading:21670469-DNA-Binding Proteins, pubmed-meshheading:21670469-Gene Expression Profiling, pubmed-meshheading:21670469-Gene Expression Regulation, Neoplastic, pubmed-meshheading:21670469-Genes, Neoplasm, pubmed-meshheading:21670469-Genetic Predisposition to Disease, pubmed-meshheading:21670469-Genetic Testing, pubmed-meshheading:21670469-Humans, pubmed-meshheading:21670469-LIM Domain Proteins, pubmed-meshheading:21670469-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:21670469-Metalloproteins, pubmed-meshheading:21670469-Middle Aged, pubmed-meshheading:21670469-Neoplasms, pubmed-meshheading:21670469-Prognosis, pubmed-meshheading:21670469-Proto-Oncogene Proteins, pubmed-meshheading:21670469-Survival Analysis, pubmed-meshheading:21670469-Tumor Markers, Biological, pubmed-meshheading:21670469-Tumor Microenvironment, pubmed-meshheading:21670469-Young Adult
pubmed:year
2011
pubmed:articleTitle
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
pubmed:affiliation
Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA. arasha@stanford.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies, Research Support, N.I.H., Extramural